| Robert William Jensen, MD | |
|
11315 Bridgeport Way Sw, Lakewood, WA 98499-3004 | |
| (253) 588-1711 | |
| (253) 581-6588 |
| Full Name | Robert William Jensen |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 23 Years |
| Location | 11315 Bridgeport Way Sw, Lakewood, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164469698 | NPI | - | NPPES |
| 0186983 | Other | WA | LIWA |
| 0186984 | Other | WA | LIWA |
| 2164JE | Other | WA | BSWA |
| 2166JE | Other | WA | BSWA |
| 8402695 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD00043539 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bozeman Health Deaconess Hospital | Bozeman, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bozeman Health Deaconess Hospital | 4688984164 | 233 |
News Archive
Verenium Corporation a pioneer in the development and commercialization of high-performance enzyme solutions, today announced that it has renewed and extended its joint marketing agreement with Alfa Laval, a leading global provider of heat transfer, separation and fluid handling technologies, for Purifine PLC.
AbbVie, a global biopharmaceutical company, today announced that it will advance ABT-494, its internally developed investigational selective JAK1 inhibitor, to Phase 3 studies in rheumatoid arthritis. Following a thorough review of available data, AbbVie will not exercise its right to in-license the Galapagos JAK1 inhibitor, filgotinib.
Almac, a leading provider of contract services to the global pharmaceutical and biotech industries, responded earlier this year to an urgent request from their client partner, Alexion Pharmaceuticals, Inc., a global biotechnology company, for packaging and distribution of Soliris (eculizumab) for patients with STEC-HUS during the E. coli outbreak in Germany earlier this year.
People with Asperger syndrome have problems with social interaction and attentiveness, and are also sensitive to noise and light. Several of these characteristics were evident to parents during their child's first two years, reveals Petra Dewrang's thesis in psychology at the University of Gothenburg.
› Verified 6 days ago
| Entity Name | Bozeman Health Big Sky Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740659952 PECOS PAC ID: 7315256872 Enrollment ID: O20151023000110 |
News Archive
Verenium Corporation a pioneer in the development and commercialization of high-performance enzyme solutions, today announced that it has renewed and extended its joint marketing agreement with Alfa Laval, a leading global provider of heat transfer, separation and fluid handling technologies, for Purifine PLC.
AbbVie, a global biopharmaceutical company, today announced that it will advance ABT-494, its internally developed investigational selective JAK1 inhibitor, to Phase 3 studies in rheumatoid arthritis. Following a thorough review of available data, AbbVie will not exercise its right to in-license the Galapagos JAK1 inhibitor, filgotinib.
Almac, a leading provider of contract services to the global pharmaceutical and biotech industries, responded earlier this year to an urgent request from their client partner, Alexion Pharmaceuticals, Inc., a global biotechnology company, for packaging and distribution of Soliris (eculizumab) for patients with STEC-HUS during the E. coli outbreak in Germany earlier this year.
People with Asperger syndrome have problems with social interaction and attentiveness, and are also sensitive to noise and light. Several of these characteristics were evident to parents during their child's first two years, reveals Petra Dewrang's thesis in psychology at the University of Gothenburg.
› Verified 6 days ago
| Entity Name | Bozeman Health Deaconess Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619347390 PECOS PAC ID: 4688984164 Enrollment ID: O20151112002559 |
News Archive
Verenium Corporation a pioneer in the development and commercialization of high-performance enzyme solutions, today announced that it has renewed and extended its joint marketing agreement with Alfa Laval, a leading global provider of heat transfer, separation and fluid handling technologies, for Purifine PLC.
AbbVie, a global biopharmaceutical company, today announced that it will advance ABT-494, its internally developed investigational selective JAK1 inhibitor, to Phase 3 studies in rheumatoid arthritis. Following a thorough review of available data, AbbVie will not exercise its right to in-license the Galapagos JAK1 inhibitor, filgotinib.
Almac, a leading provider of contract services to the global pharmaceutical and biotech industries, responded earlier this year to an urgent request from their client partner, Alexion Pharmaceuticals, Inc., a global biotechnology company, for packaging and distribution of Soliris (eculizumab) for patients with STEC-HUS during the E. coli outbreak in Germany earlier this year.
People with Asperger syndrome have problems with social interaction and attentiveness, and are also sensitive to noise and light. Several of these characteristics were evident to parents during their child's first two years, reveals Petra Dewrang's thesis in psychology at the University of Gothenburg.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert William Jensen, MD 505 S 336th St, Suite 600, Federal Way, WA 98003-6328 Ph: (253) 838-6180 | Robert William Jensen, MD 11315 Bridgeport Way Sw, Lakewood, WA 98499-3004 Ph: (253) 588-1711 |
News Archive
Verenium Corporation a pioneer in the development and commercialization of high-performance enzyme solutions, today announced that it has renewed and extended its joint marketing agreement with Alfa Laval, a leading global provider of heat transfer, separation and fluid handling technologies, for Purifine PLC.
AbbVie, a global biopharmaceutical company, today announced that it will advance ABT-494, its internally developed investigational selective JAK1 inhibitor, to Phase 3 studies in rheumatoid arthritis. Following a thorough review of available data, AbbVie will not exercise its right to in-license the Galapagos JAK1 inhibitor, filgotinib.
Almac, a leading provider of contract services to the global pharmaceutical and biotech industries, responded earlier this year to an urgent request from their client partner, Alexion Pharmaceuticals, Inc., a global biotechnology company, for packaging and distribution of Soliris (eculizumab) for patients with STEC-HUS during the E. coli outbreak in Germany earlier this year.
People with Asperger syndrome have problems with social interaction and attentiveness, and are also sensitive to noise and light. Several of these characteristics were evident to parents during their child's first two years, reveals Petra Dewrang's thesis in psychology at the University of Gothenburg.
› Verified 6 days ago
Kelly A Phillips, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11315 Bridgeport Way Sw, Emergency Dept, Lakewood, WA 98499 Phone: 253-985-8700 | |
Mrs. Tiffany C Crabb, PA-C Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 7308 Bridgeport Way W, Suite 201, Lakewood, WA 98499 Phone: 253-582-7257 Fax: 253-582-1617 | |
Matthew M Rice, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 11315 Bridgeport Way Sw, Lakewood, WA 98499 Phone: 253-588-1711 Fax: 253-581-6588 | |
James Bae Lee, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 11315 Bridgeport Way Sw, Lakewood, WA 98499 Phone: 253-588-1711 Fax: 253-944-7922 | |
Sean Thomas Baxter, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11315 Bridgeport Way Sw, Lakewood, WA 98499 Phone: 253-589-8700 Fax: 253-581-6588 | |
Michael J Larson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11315 Bridgeport Way Sw, Lakewood, WA 98499 Phone: 253-588-1711 Fax: 253-838-6418 |